Cargando…
In vivo and in vitro studies on the roles of p38 mitogen-activated protein kinase and NADPH-cytochrome P450 reductase in Alzheimer's disease
Alzheimer's disease (AD) is a chronic neurodegenerative disease with an increasing morbidity rate. As one of the most important signaling pathways that responds to inflammation and degeneration, the p38 mitogen-activated protein kinase (MAPK) signaling pathway is active in the cortexes of AD mi...
Autores principales: | Yao, Yunyi, Huang, Jin-Zhong, Chen, Liang, Chen, Yingqi, Li, Xianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704317/ https://www.ncbi.nlm.nih.gov/pubmed/29201176 http://dx.doi.org/10.3892/etm.2017.5182 |
Ejemplares similares
-
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023) -
Nitroreduction of flutamide by Cunninghamella elegans NADPH: Cytochrome P450 reductase
por: Khan, Mohd Faheem, et al.
Publicado: (2022) -
Contribution of NADPH-cytochrome P450 Reductase to Azole Resistance in Fusarium oxysporum
por: He, Dan, et al.
Publicado: (2021) -
Cloning and Functional Characterization of NADPH-Cytochrome P450 Reductases in Aconitum vilmorinianum
por: Cheng, Jingping, et al.
Publicado: (2023) -
The Flavin-Containing Reductase Domain of Cytochrome P450 BM3 Acts as a Surrogate for Mammalian NADPH-P450 Reductase
por: Park, Seon-Ha, et al.
Publicado: (2012)